早期非小细胞肺癌的免疫疗法:当前争议的实用指南
William J Phillips1, Ashley Jackson2, Biniam Kidane3
1Department of Medicine, University of Ottawa, Ottawa, Ontario, Canada.
Clinical lung cancer
|February 1, 2025
概括
免疫疗法正在改变非小细胞肺癌 (NSCLC) 治疗. 本综述涵盖了最近的试验,并讨论了这种不断发展的治疗方法的关键临床实践挑战.
科学领域:
- 在瘤学瘤学.
- 肺部病理学 肺部病理学
- 免疫治疗是一种免疫疗法.
背景情况:
- 免疫疗法已迅速发展成为非小细胞肺癌 (NSCLC) 的全身治疗方法.
- 许多第三期临床试验现在正在研究各种治疗环境中的免疫疗法:新辅助,外科手术,辅助和非手术.
- 这种不断变化的环境需要对当前数据和未来方向有明确的理解.
研究的目的:
- 为提供免疫治疗在非小细胞肺癌 (NSCLC) 的综合叙事审查.
- 总结不同治疗环境中关键的第三期临床试验数据.
- 讨论和澄清这些发现在临床应用中的当前争议.
主要方法:
- 对评估NSCLC免疫治疗的第三期临床试验的系统文献搜索.
- 试验数据的叙述综合,重点关注疗效和安全性.
- 分析临床实践的争议和专家意见.
主要成果:
- 免疫疗法在NSCLC的各种环境中显示出显著的疗效.
- 关于术后治疗中的辅助作用,PD-L1阴性瘤的治疗以及定义切除能力的争议仍然存在.
- 最佳的管理策略,包括手术与非手术方法以及放射治疗的作用,需要进一步澄清.
结论:
- 免疫疗法是NSCLC治疗的基石,正在进行的研究解决了特定的临床困境.
- 需要进一步的研究和共识,以优化在不同NSCLC患者群体和环境中使用免疫疗法.
- 解决争议将完善治疗方案,改善非小细胞肺癌患者的治疗结果.
更多相关视频
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
4.8K
04:04Endobronchial Ultrasound-guided Intratumoral Injection of Cisplatin for the Treatment of Isolated Mediastinal Recurrence of Lung Cancer
Published on: February 12, 2017
10.4K
相关概念视频
Tumor Immunotherapy
464
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
464
Cancer Therapies
7.5K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
7.5K
Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
Cancer Vaccines
329
Cancer treatment vaccines are a rapidly evolving field that offers a promising approach to immunotherapy. Unlike traditional vaccines that prevent diseases, cancer treatment vaccines are designed to treat existing cancers by stimulating the immune system to recognize and attack cancer cells.
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
Cancer vaccines come in two categories: preventive (prophylactic) and treatment (active). Preventive vaccines, such as the Human Papillomavirus (HPV) vaccine, protect against viruses that cause certain...
329
Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K
